Telemedicine Prescribing: Critical Elements of the 2025 Proposed and Final Rules
The Drug Enforcement Administration and the Department of Health and Human Services recently released the long-awaited (updated) proposed rule for prescribing controlled substances through telemedicine, as well as the final rule on expansion of buprenorphine treatment through telemedicine. These rules represent a significant evolution in telemedicine regulation, with critical implications for health care providers and entities involved in the provision of telemedicine services.
Join Hall Render attorneys Chris Eades and Mayo Alao as they explore the intricacies and potential impact of these new and proposed rules—with a particular emphasis on where and how these rules differ from the COVID-era flexibilities. Attendees will leave this webinar with a basic understanding of these new/proposed rules, what they each entail, and considerations for related compliance obligations moving forward.
This session is a must-attend event for anyone involved in the provision of telemedicine services or responsible for ensuring legal compliance in this evolving regulatory landscape.
Watch Video Below (Available beginning 2/27/25) | Download Slides
